The ‘myth of Hydroxychloroquine (HCQ) as post-exposure prophylaxis (PEP) for the prevention of COVID-19’ is far from reality

The efficacy of Hydroxychloroquine (HCQ) as post-exposure prophylaxis (PEP) for the prevention of COVID-19 was contentious. In this randomized control double-blind clinical trial, asymptomatic individuals with direct contact with laboratory-confirmed COVID-19 cases were randomized into PEP/HCQ (N = ...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhibar, Deba Prasad, Arora, Navneet, Chaudhary, Deepak, Prakash, Ajay, Medhi, Bikash, Singla, Neeraj, Mohindra, Ritin, Suri, Vikas, Bhalla, Ashish, Sharma, Navneet, Singh, Mini P., Lakshmi, P. V. M., Goyal, Kapil, Ghosh, Arnab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825075/
https://www.ncbi.nlm.nih.gov/pubmed/36611040
http://dx.doi.org/10.1038/s41598-022-26053-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825075/
https://www.ncbi.nlm.nih.gov/pubmed/36611040
http://dx.doi.org/10.1038/s41598-022-26053-w

Ejemplares similares